Skip to main content
Journal cover image

An expert opinion on heart failure in hypertensive heart disease.

Journal articles  - Review, Journal Article
Díez, J; González, A; Kirabo, A; Verdecchia, P; Jafar, TH; Aune, D; Laffin, LJ; Burkard, T; Rosano, GM; Piepoli, M; Richards, AM; López, B ...
Published in: European journal of heart failure
May 2026

There is strong evidence that hypertension is a major risk factor for heart failure (HF). Hypertension contributes to incident HF through direct and indirect effects. Indirect effects are consequences of ischaemic heart disease because hypertension facilitates atherosclerotic obstructive coronary artery disease. The direct effects are straightly related to hypertensive heart disease (HHD). Hypertensive heart disease poses a significant challenge with substantial medical and public health implications. Efforts should be made to recognize and manage HHD in a timely manner and optimize hypertension treatment. Reducing blood pressure (BP) and/or reassessing antihypertensive therapy using traditional or novel approaches can halt or delay progression to HF in patients with HHD and possibly prevent it. However, HHD's importance as a risk factor for overt HF is often overlooked in clinical practice. This document aims to summarize the current understanding of the burden of HHD and its risk for incident HF, discuss the mechanisms underlying HHD-related HF onset and progression, consider how diagnostic tools contribute to individualized phenotyping and HF risk stratification of HHD, address how therapeutic measures ameliorating or even preventing structural and functional alterations of HHD, along with BP control influence HHD-associated HF risk.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

European journal of heart failure

DOI

EISSN

1879-0844

ISSN

1388-9842

Publication Date

May 2026

Volume

28

Issue

2

Start / End Page

217 / 232

Related Subject Headings

  • Ventricular Remodeling
  • Risk Factors
  • Hypertension
  • Humans
  • Heart Failure
  • Disease Progression
  • Cardiovascular System & Hematology
  • Antihypertensive Agents
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Díez, J., González, A., Kirabo, A., Verdecchia, P., Jafar, T. H., Aune, D., … Butler, J. (2026). An expert opinion on heart failure in hypertensive heart disease. European Journal of Heart Failure, 28(2), 217–232. https://doi.org/10.1093/ejhf/xuag004
Díez, Javier, Arantxa González, Annet Kirabo, Paolo Verdecchia, Tazeen H. Jafar, Dagfinn Aune, Luke J. Laffin, et al. “An expert opinion on heart failure in hypertensive heart disease.European Journal of Heart Failure 28, no. 2 (May 2026): 217–32. https://doi.org/10.1093/ejhf/xuag004.
Díez J, González A, Kirabo A, Verdecchia P, Jafar TH, Aune D, et al. An expert opinion on heart failure in hypertensive heart disease. European journal of heart failure. 2026 May;28(2):217–32.
Díez, Javier, et al. “An expert opinion on heart failure in hypertensive heart disease.European Journal of Heart Failure, vol. 28, no. 2, May 2026, pp. 217–32. Epmc, doi:10.1093/ejhf/xuag004.
Díez J, González A, Kirabo A, Verdecchia P, Jafar TH, Aune D, Laffin LJ, Burkard T, Rosano GM, Piepoli M, Richards AM, López B, Ravassa S, Chin CWL, Messerli FH, Marwick TH, Camafort M, de Simone G, Zhang J, Pitt B, Tadic M, Cuspidi C, Zannad F, Metra M, Böhm M, Butler J. An expert opinion on heart failure in hypertensive heart disease. European journal of heart failure. 2026 May;28(2):217–232.
Journal cover image

Published In

European journal of heart failure

DOI

EISSN

1879-0844

ISSN

1388-9842

Publication Date

May 2026

Volume

28

Issue

2

Start / End Page

217 / 232

Related Subject Headings

  • Ventricular Remodeling
  • Risk Factors
  • Hypertension
  • Humans
  • Heart Failure
  • Disease Progression
  • Cardiovascular System & Hematology
  • Antihypertensive Agents
  • 3201 Cardiovascular medicine and haematology